The characteristics of SARS-CoV-2-positive children who presented to Australian hospitals during 2020: a PREDICT network study
- PMID: 34389995
- PMCID: PMC8447363
- DOI: 10.5694/mja2.51207
The characteristics of SARS-CoV-2-positive children who presented to Australian hospitals during 2020: a PREDICT network study
Abstract
Objectives: To examine the epidemiological and clinical characteristics of SARS-CoV-2-positive children in Australia during 2020.
Design, setting: Multicentre retrospective study in 16 hospitals of the Paediatric Research in Emergency Departments International Collaborative (PREDICT) network; eleven in Victoria, five in four other Australian states.
Participants: Children aged 0-17 years who presented to hospital-based COVID-19 testing clinics, hospital wards, or emergency departments during 1 February - 30 September 2020 and who were positive for SARS-CoV-2.
Main outcome measures: Epidemiological and clinical characteristics of children positive for SARS-CoV-2.
Results: A total of 393 SARS-CoV-2-positive children (181 girls, 46%) presented to the participating hospitals (426 presentations, including 131 to emergency departments [31%]), the first on 3 February 2020. Thirty-three children presented more than once (8%), including two who were transferred to participating tertiary centres (0.5%). The median age of the children was 5.3 years (IQR, 1.9-12.0 years; range, 10 days to 17.9 years). Hospital admissions followed 51 of 426 presentations (12%; 44 children), including 17 patients who were managed remotely by hospital in the home. Only 16 of the 426 presentations led to hospital medical interventions (4%). Two children (0.5%) were diagnosed with the paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS).
Conclusion: The clinical course for most SARS-CoV-2-positive children who presented to Australian hospitals was mild, and did not require medical intervention.
© 2021 AMPCo Pty Ltd.
Conflict of interest statement
No relevant disclosures.
Figures

Comment in
-
COVID-19 in children: time for a new strategy.Med J Aust. 2021 Sep 6;215(5):212-213. doi: 10.5694/mja2.51206. Epub 2021 Aug 2. Med J Aust. 2021. PMID: 34337751 Free PMC article. No abstract available.
References
-
- Lavezzo E, Franchin E, Ciavarella C, et al; Imperial College COVID‐19 Response Team . Suppression of a SARS‐CoV‐2 outbreak in the Italian municipality of Vo’. Nature 2020; 584: 425–429. - PubMed
-
- Zimmermann P, Curtis N. Why is COVID‐19 less severe in children? A review of the proposed mechanisms underlying the age‐related difference in severity of SARS‐CoV‐2 infections. Arch Dis Child 2021; 106: 429–439. - PubMed
-
- Graff K, Smith C, Silveira L, et al. Risk factors for severe COVID‐19 in children. Pediatr Infect Dis J 2021; 40: e137–e145. - PubMed
Publication types
MeSH terms
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous